EIF4EBP1 and colorectal carcinoma: Zhang et al. found that mTOR, p70s6 K, and 4EBP1 were highly expressed in HIN and CRC compared with normal mucosa (NM), and mTOR gene silencing was implicated as a novel therapeutic strategy for CRC [6].